Latest Whitepapers
Whitepaper
The End of End-Point Assays
This whitepaper highlights the recent developments and performance of three modular benchtop solutions for the high-performance quantitation and kinetics characterization of proteins and their small molecule interactions.
Whitepaper
Streamlining Affinity Analysis for Accelerated Drug Discovery
This whitepaper highlights the features and capabilities of a novel system for streamlining affinity analysis for rapid lead molecule screening.
Whitepaper
Diving Deep Into Cell Therapy: An Industry Perspective
Active cell therapy drugs represent the latest in cancer treatment. Of these, chimeric antigen receptor (CAR) cell modalities are considered the most successful.
Whitepaper
Solid Form Informatics for Pharmaceuticals and Fine Chemicals
Solid form informatics (SFI) provides a knowledge-based approach to improve the effectiveness and quality of early-phase drug discovery research, as well as a rational approach to risk assessment.
Whitepaper
Genetic Insights for Biopharmaceuticals: Propelling Drug Candidates into Therapeutic Assets
Innovation is key for any biopharmaceutical and biotechnology company. Whilst the demand for infectious disease prevention continues to grow, so does the pressure on these companies to deliver innovative solutions.
Whitepaper
Fast, Sensitive and Robust Host Cell Protein Analysis
Process development teams need detailed information, via a platform that delivers short gradients to allow the required sample throughput to detect HCPs in a low sub-ppm range.
Whitepaper
Advanced Flow Cytometry Applications for Antibody, Small Molecule and Phenotypic Screening
Flow cytometry is an important part of the drug discovery workflow. From screening antibodies to small molecules, combining tests for various analytes in a single panel not only reduces the necessary sample volume but also collects more information in less time, accelerating the drug discovery process.
Whitepaper
Top Five Considerations When Making Decisions for a More Robust Harvest
Download this whitepaper to explore considerations when selecting a harvest technology such as sustainability, time and cost as well as space and scale.
Whitepaper
Accelerating Drug Discovery With Real-Time Kinetic and Affinity Analysis
Bioassays, such as the enzyme-linked bioabsorbant assay (ELISA), are standard techniques that require enzyme or fluorescent labels for the detection of target analytes. While these label-based studies give important information about a sample, such as binding affinity, they can only measure the interaction of an analyte at a given concentration and time, and are unable to gather kinetic analysis.
Whitepaper
High Quality Analytical Reagents Accelerate Pharmaceutical Development
For the very first time since its publication, ACS Reagent Chemicals is now available online in a seamless, searchable database. If you are a producer of pharmaceuticals, download this whitepaper to learn how this invaluable resource can benefit your organization.
Advertisement